Form D · Other Health Care

AgNovos Bioscience, Inc.

Rockville, MD · CIK 0001979715

Offering snapshot reported Mar 12, 2024 · SEC filing

Reported sold
$13.4M
Offering amount: $13.4M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 20, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 12, 2024Initial$13,377,366No comparison8SEC filing
Jun 9, 2023Initial$31,471,917No comparison4SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-507268

Source: Form D, filed Mar 12, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
James Barry Director
Bill Beasley Executive
Falk Dukatz Executive
Jason Foley Executive
Chris Gegeyls Executive
James G. Howe Director, Executive
Stephanie Kladakis Executive
Adam Lowe Executive
James Pilachowski Executive
Michael Schmertzler Director
James Shimp Executive
Robert Stiller Director
David Stiller Director
Dawn Svoronos Director
Nick Valeriani Director
Jarrett Waldner Executive
Ellen Zane Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:
7301 Calhoun Place Suite 100
Rockville, MD, 20855